docetaxel anhydrous has been researched along with Cancer of Nose in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirai, Y; Ito, S; Kawashima, H; Kurosaki, Y; Uekusa, T | 1 |
| Fukuda, S; Furusawa, J; Hatakeyama, H; Homma, A; Kano, S; Mizumachi, T; Nakamaru, Y; Onimaru, R; Sakashita, T; Shirato, H; Terasaka, S; Tsuchiya, K; Yasuda, K; Yoshida, D | 1 |
| Hah, JH; Han, DH; Heo, DS; Keam, B; Kim, DW; Kim, DY; Kim, TM; Kwon, TK; Lee, SH; Ock, CY; Rhee, CS; Sung, MW; Won, TB; Wu, HG | 1 |
| Chen, L; Chen, NX; Ma, L; Wang, JL; Yan, F; Zhang, XX | 1 |
| Asano, Y; Furuichi, M; Makino, T; Norisugi, O; Shimizu, T | 1 |
| Deguchi, K; Kurono, Y; Nagano, H; Yoshifuku, K | 1 |
| Bolotina, LV; Kornietskaia, AL | 1 |
| Doi, T; Fuse, N; Hayashi, R; Kawashima, M; Ogino, T; Ohtsu, A; Okano, S; Tahara, M; Yoshino, T; Zenda, S | 1 |
1 trial(s) available for docetaxel anhydrous and Cancer of Nose
| Article | Year |
|---|---|
[Induction therapy of locally-advanced nasophayngeal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Nose Neoplasms; Pharyngeal Neoplasms; Radiotherapy, Adjuvant; Remission Induction; Taxoids; Treatment Outcome | 2011 |
7 other study(ies) available for docetaxel anhydrous and Cancer of Nose
| Article | Year |
|---|---|
[A case with double primary cancers in both lung and nasal cavity].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Docetaxel; Fatal Outcome; Humans; Lung Neoplasms; Male; Nasal Cavity; Neoplasms, Multiple Primary; Nose Neoplasms; Taxoids | 2013 |
Management for squamous cell carcinoma of the nasal cavity and ethmoid sinus: A single institution experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Cohort Studies; Docetaxel; Endoscopy; Ethmoid Sinus; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nasal Cavity; Neoplasm Staging; Nose Neoplasms; Organoplatinum Compounds; Otorhinolaryngologic Surgical Procedures; Paranasal Sinus Neoplasms; Radiotherapy, Adjuvant; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2015 |
Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Docetaxel; Eye; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Medical Records; Middle Aged; Nasal Cavity; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Nose Neoplasms; Organ Sparing Treatments; Paranasal Sinus Neoplasms; Proportional Hazards Models; Retrospective Studies; Risk Factors; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Taxoids; Time Factors; Treatment Outcome; Young Adult | 2016 |
[Clinical analysis of multimodal treatment for orbital organ preservation in T4b squamous cell carcinoma of nasal cavity and paranasal sinuses].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; ErbB Receptors; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Nasal Cavity; Nose Neoplasms; Organ Sparing Treatments; Paranasal Sinus Neoplasms; Quality of Life; Radiation Injuries; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome | 2016 |
Effective treatment of angiosarcoma on the nose by combination treatment with electron beam irradiation, recombinant interleukin-2 and docetaxel.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Electrons; Fatal Outcome; Hemangiosarcoma; Humans; Interleukin-1; Lung Neoplasms; Male; Nose Neoplasms; Recombinant Proteins; Taxoids; Tomography, X-Ray Computed | 2009 |
Adenocarcinoma of the paranasal sinuses and nasal cavity with lung metastasis showing complete response to combination chemotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF): a case report.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Fluorouracil; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Nose Neoplasms; Paranasal Sinus Neoplasms; Taxoids; Treatment Outcome | 2010 |
Induction chemotherapy with docetaxel, cisplatin and S-1 followed by proton beam therapy concurrent with cisplatin in patients with T4b nasal and sinonasal malignancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Drug Combinations; Female; Humans; Induction Chemotherapy; Male; Middle Aged; Nose Neoplasms; Oxonic Acid; Paranasal Sinus Neoplasms; Proton Therapy; Taxoids; Tegafur | 2012 |